Table 1 Cases of Mycobacterium farcinogenes–senegalense group
Age/sex | Immune state | Country | Species | Infection site | trauma | Treatment course | |
|---|---|---|---|---|---|---|---|
Oh et al. [4] | 49/F | Immunocompromised (non-Hodgkin’s lymphoma) | Korea | M. senegalense | Blood stream (catheter related) | None | Imipenem/cilastatin and amikacin then ciprofloxacin and doxycycline for 4 weeks |
Wong et al. [5] | 67/F | Immunocompetent | Hong Kong | M. farcinogenes | Prosthetic joint | Toal hip arthroplasty | Surgical removal of implant and debridement; ciprofloxacin and doxycycline intravenously for 6 weeks and then orally for 3 months |
Talavlikar et al. [6] | 3/F | Immunocompetent | America | M. senegalense | Soft tissue | Fish tank | Clarithromycin, trimethoprim/sulfamethoxazole and ciprofloxacin for 3 months |
Maupin et al. [7] | 55/M | Immunocompetent | America | M. senegalense | Bone | Traumatic ankle fracture (motor vehicle collision: from the driver’s seat into a pasture ditch) | Surgical removal of implant and debridement; imipenem, ciprofloxacin, and minocycline for 6 weeks, then imipenem, linezolid and azithromycin for 3 months, then linezolid, azithromycin, and doxycycline for another 3 months |
Al Farsi et al. [8] | 49/M | Immunocompromised (diabetes mellitus) | Oman | M. farcinogenes | Bone | Anterior cruciate ligament and medial meniscal repair | Surgical removal of implant and debridement; ciprofloxacin and doxycycline for 6 months |
Kashihara et al. [9] | 37/M | Immunocompetent | Japan | M. farcinogenes | Bone | Traumatic tibia and fibula fracture (concrete) | Surgical debridement; levofloxacin, amikacin, and rifampin for 12 months |
Our case (2022) | 66/F | Immunocompetent | Taiwan | M. farcinogenes–senegalense group | Skin | Trashed mattress | Clarithromycin and sulfamethoxazole/trimethoprim for 2 months followed by surgical excision (sulfamethoxazole/trimethoprim was discontinued at 2 weeks due to intolerance) |